Kuoppala T, Tuimala R, Parviainen M, Koskinen T
Eur J Obstet Gynecol Reprod Biol. 1986 Oct;23(1-2):45-51. doi: 10.1016/0028-2243(86)90103-6.
Serum concentrations of 25(OH)D, 24,25(OH)2D, 1,25(OH)2D, total protein, calcium, phosphorus, magnesium and alkaline phosphatase were measured in patients with intrahepatic cholestasis of pregnancy and in control subjects at the third trimester of pregnancy and at delivery. 25(OH)D levels of 40.5 +/- 21.5 nmol/l in the patient group were initially significantly (P less than 0.01) higher than the value of 26.3 +/- 9.5 nmol/l in the control group and decreased significantly (P less than 0.01) to 26.0 +/- 16.3 nmol/l at delivery. The levels of active 1,25(OH)2D and inactive 24,25(OH)2D did not alter in either group. Also the concentrations of calcium, phosphorus and magnesium remained unchanged in both groups. No significant differences in fetal vitamin D metabolites were observed between patients and controls, and the other analysed fetal parameters were similar in both groups. Cholestyramine and/or phenobarbital treatment had no influence on vitamin D metabolites. Since levels of 1,25(OH)2D and mineral parameters remained normal and a change in 25(OH)D concentrations was only transient, the clinical role of 25(OH)D variations cannot be substantial.
对妊娠肝内胆汁淤积症患者以及处于妊娠晚期和分娩时的对照组受试者,测定其血清中25(OH)D、24,25(OH)₂D、1,25(OH)₂D、总蛋白、钙、磷、镁和碱性磷酸酶的浓度。患者组的25(OH)D水平最初为40.5±21.5 nmol/l,显著高于对照组的26.3±9.5 nmol/l(P<0.01),而在分娩时显著下降至26.0±16.3 nmol/l(P<0.01)。两组中活性1,25(OH)₂D和非活性24,25(OH)₂D的水平均未改变。两组中钙、磷和镁的浓度也保持不变。患者与对照组之间未观察到胎儿维生素D代谢产物有显著差异,且两组中其他分析的胎儿参数相似。考来烯胺和/或苯巴比妥治疗对维生素D代谢产物无影响。由于1,25(OH)₂D水平和矿物质参数保持正常,且25(OH)D浓度的变化只是短暂的,因此25(OH)D变化的临床作用可能不大。